Article
New molecular abnormalities and clonal architecture in AML: from reciprocal translocations to whole-genome sequencing.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting - 1 Jan 2014
Graubert Timothy A, Brunner Andrew M, Fathi Amir T
Abstract excerpt
Acute myeloid leukemia (AML) is characterized by recurrent genetic alterations, including amplifications, deletions, rearrangements, and point mutations. Clinically, these lesions can be used to stratify patients into categories of risk, which directs further clinical management and prognostication. Patient risk categories were first described based on recurrent karyotypic abnormalities; most patients with AML,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
